This company has shut down. Senda Biosciences is no longer operating — its last tracked round was a Series C in 2022.
Explore the Startup GraveyardSenda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
Senda Biosciences has raised $123.0M in total funding. The most recent round was Series C. The last funding was announced in August 2022.
Senda Biosciences's investors include Qatar Investment Authority, Flagship Pioneering, Mayo Clinic, Alexandria Venture Investments, Partners Investment.
Senda Biosciences is headquartered in Cambridge, United States.
Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
Senda Biosciences is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Senda Biosciences — Funding & Investors." VCBacked, August 16, 2022, https://www.vcbacked.co/company/senda-biosciences. Accessed September 29, 2026.
VCBacked. (2022). Senda Biosciences — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/senda-biosciences
{{cite web |title=Senda Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/senda-biosciences |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated